The nation of Zimbabwe has rejected a major American health deal valued at $367m (£272m) spanning five years because of the United States' demand for confidential biological samples.
This rejection was revealed following a government memo dated December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "unbalanced".
An official spokesman later explained that the US was demanding access to health data for research and profit while was not willing to guarantee the resulting advantages from any future treatments.
"We are forced to start the challenging and unfortunate task of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for further dialogue to find a deal acceptable to all parties so the nation's vital HIV programme can continue.
Broader Background
This rejection comes after a comparable case in Kenya, where a high court suspended a similar health funding agreement after concerns were filed about the security of citizens' health data.
Since returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
USAID had overseen aid for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to enhance openness and responsibility.
According to reports, 16 African countries have so far agreed to similar health pacts, representing more than $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment via American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, without any equivalent assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that shared data," he stated.
"Put simply, our nation would supply the basic resources for scientific discovery without any assurance that the end products would be accessible to our population should a new health crisis arise."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were disrupting frameworks previously set up through the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to deal with potential global health emergencies.
"This system is designed to guarantee that when a country contributes its samples, the benefits – including medicines and cures – are shared equitably, not monopolised solely by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We encourage continued dialogue with our American counterparts on how future collaboration might be structured in a way that respects the sovereignty and interests of both nations."
Health Experts Response
Medical experts said it acknowledged the government's concerns, but urged that negotiations should continue since much of the nation's HIV programmes depended on external financing.
"If technical issues exist, including those relating to data governance or agreement terms, these can often be addressed via detailed discussion and negotiated safeguards," it added.
The situation underscores the ongoing challenges between receiving crucial international aid and safeguarding local interests in an ever more interconnected world.